[1] Bellucci E, Terenzi R, La Paglia GM, et al. One year in review 2016:pathogenesis of rheumatoid arthritis[J]. Clin Exp Rheumatol, 2016, 34(5):793-801. [2] Angelotti F, Parma A, Cafaro G, et al. One year in review 2017:pathogenesis of rheumatoid arthritis[J]. Clin Exp Rheumatol, 2017, 35(3):368-378. [3] Picerno V, Ferro F, Adinolfi A, et al. One year in review:the pathogenesis of rheumatoid arthritis[J]. Clin Exp Rheumatol, 2015, 33(4):551-558. [4] Wei XJ, Li XW, Lu JL, et al. MiR-20a regulates fibroblast-like synoviocyte proliferation and apoptosis in rheumatoid arthritis[J]. Eur Rev Med Pharmacol Sci, 2017, 21(17):3886-3893. [5] Hong BK, You S, Yoo SA, et al. MicroRNA-143 and-145 modulate the phenotype of synovial fibroblasts in rheumatoid arthritis[J]. Exp Mol Med, 2017, 49(8):e363. [6] Liu J, Fei D, Xing J, et al. MicroRNA-29a inhibits proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by repressing STAT3[J]. Biomed Pharmacother, 2017, 96:173-181. [7] Churov AV, Oleinik EK, Knip M. MicroRNAs in rheumatoid arthritis:altered expression and diagnostic potential[J]. Autoimmun Rev, 2015, 14(11):1029-1037. [8] Wang Y, Wang D, Guo D. MiR-124 promote neurogenic transdifferentiation of adipose derived mesenchymal stromal cells partly through RhoA/ROCK1, but Not ROCK2 signaling pathway[J]. PLoS One, 2016, 11(1):e0146646. [9] Sun Y, Luo Z M, Guo X M, et al. An updated role of microRNA-124 in central nervous system disorders:a review[J]. Front Cell neurosci, 2015, 9(193):1-8. [10] Zhang J, Lu Y, Yue X, et al. MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3[J]. PLoS One, 2013, 8(8):e70300. [11] Feng T, Xu D, Tu C, et al. miR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4[J]. Tumour Biol, 2015, 36(8):5987-5997. [12] Nakamachi Y, Ohnuma K, Uto K, et al. MicroRNA-124 inhibits the progression of adjuvant-induced arthritis in rats[J]. Ann Rheum Dis, 2016,75(3):601-608. [13] Haringman JJ, Gerlag DM, Zwinderman AH, et al. Synovial tissue macrophages:a sensitive biomarker for response to treatment in patients with rheumatoid arthritis[J]. Ann Rheumatic Dis, 2005, 64(6):834-838. [14] Kinne RW, Stuhlmüller B, Burmester GR. Cells of the synovium in rheumatoid arthritis. Macrophages[J]. Arthritis Res Ther, 2007, 9(6):224. [15] Khoury M, Louis-Plence P, Escriou V, et al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor in experimental arthritis[J]. Arthritis Rheum, 2006, 54(6):1867-1877. [16] Lubberts E. Role of T lymphocytes in the development of rheumatoid arthritis Implications for treatment[J].Curr Pharm Des, 2015, 21(2):142-146. [17] Yokota S, Tanaka T, Kishimoto T. Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis[J]. Ther Adv Musculoskel Dis, 2012,4(6):387-397. [18] Mcinnes IB, Buckley CD, Isaacs JD. Cytokines in rheumatoid arthritis-shaping the immunological landscape[J]. Nat Rev Rheumatol, 2016, 12(1):63-68. [19] Sun Y, Li Q, Gui H, et al. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines[J]. Cell Res,2013,23(11):1270-1283. [20] Qiu S, Feng Y, LeSage G, et al. Chronic morphine-induced microrna-124 promotes microglial immunosuppression by modulating P65 and TRAF6[J]. J Immunol,2015,194(3):1021-1030 [21] 王易林,胡明冬.过氧化物酶增殖体激活受体γ通过上调miR-124表达抑制急性肺损伤肺泡巨噬细胞炎症反应[J].中华肺部疾病杂志电子版,2015,8(2):19-23. [22] Nakamachi Y, Kawano S, Takenokuchi M, et al. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis[J]. Arthritis Rheum, 2009, 60(5):1294-1304. |